Clinical Trials Directory

Trials / Unknown

UnknownNCT06181981

Leucoaraiosis and Multimodal MRI With Fingerprinting Technique

Longitudinal Evaluation of Leucoaraiosis Using Multimodal MRI With Fingerprinting Technique

Status
Unknown
Phase
Study type
Observational
Enrollment
250 (estimated)
Sponsor
Lille Catholic University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Leukoaraiosis (LA) corresponds to an alteration of the encephalic white matter, linked to chronic hypoxia. Its pathophysiology, which has been partially elucidated, is underpinned by chronic changes in the walls of small-caliber perforating arteries, leading to chronic hypoperfusion of the white matter, associated with dysfunction of the blood-brain barrier. In affected areas, this process leads to myelin rarefaction, axonal loss, perivascular alterations and the appearance of cavitation zones. Its existence is mainly linked to the presence of vascular risk factors, most notably arterial hypertension. MR fingerprinting is an innovative Magnetic resonance Imaging (MRI) technique allowing to obtain a multiparametric MRI sequence in a non-invasively way and in a single acquisition, generating not only multiple contrasts, but also absolute longitudinal relaxation time (T1) and transverse relaxation time (T2) mappings (T1 and T2 mapping). However, the prognostic role of these T2 values, in terms of ischemic, hemorrhagic and cognitive risk, has never been studied. The objective of this study is to study and compare changes in T1 and T2 values of White Matter Hyperintensities (WMH) and Normal Appearing White Matter (NAWM) in subjects with LA.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTMRI fingerprintingThis method allows to get quantitative magnetic resonance imaging for the simultaneous measurement of multiple tissue properties in a single, time-efficient acquisition

Timeline

Start date
2022-11-14
Primary completion
2024-11-30
Completion
2025-11-30
First posted
2023-12-26
Last updated
2023-12-26

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06181981. Inclusion in this directory is not an endorsement.